BiotechTubeBiotechTube
Home/Alnylam Pharmaceuticals/Yvonne Greenstreet
YG

Yvonne Greenstreet

Chief Executive Officer

Alnylam Pharmaceuticals

Therapeutic Areas

Rare DiseasesGenetic DisordersAmyloidosisPorphyriaPrimary HyperoxaluriaCardiovascularNeurology

Alnylam Pharmaceuticals Pipeline

DrugIndicationPhase
Patisiran (ONPATTRO)Hereditary Transthyretin AmyloidosisApproved
Givosiran (GIVLAARI)Acute Hepatic PorphyriaApproved
Lumasiran (OXLUMO)Primary Hyperoxaluria Type 1Approved
Inclisiran (LEQVIO)HypercholesterolemiaApproved
VutrisiranHereditary Transthyretin AmyloidosisPhase 3
ALN-AGT01HypertensionPhase 1
ALN-KHKPrimary HyperoxaluriaPhase 3
ALN-APPAlzheimer's DiseasePhase 1

Leadership Team at Alnylam Pharmaceuticals

JP
Jeffrey Poulton
Chief Financial Officer
AV
Akshay Vaishnaw
President
TT
Tolga Tanguler
Chief Commercial Officer
PG
Pushkal Garg
Chief Medical Officer
RH
Renta Hutabarat
Executive Vice President, Head of Research
AS
Amy Simon
Chief Human Resources Officer
CR
Christine Regan Lindenboom
Executive Vice President, General Counsel
View full Alnylam Pharmaceuticals profile